全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2019 

Endovascular thrombectomy in anterior circulation stroke and clinical value of bridging with intravenous thrombolysis

DOI: 10.1177/0284185118780897

Keywords: Thrombectomy,bridging,stroke,thrombolysis,hemorrhage,CT perfusion

Full-Text   Cite this paper   Add to My Lib

Abstract:

Bridging treatment with intravenous thrombolysis (IVT) before endovascular thrombectomy (EVT) in acute ischemic stroke is applied under the assumption of benefits for patients with large vessel occlusion (LVO). However, the benefit of this additional step has not yet been proven. To compare procedural parameters (procedural time, number of attempts), complications, and clinical outcome in patients receiving EVT vs. patients with bridging treatment. In this prospective study all patients had acute anterior cerebral circulation occlusion and were treated with EVT. All patients were selected for treatment based on clinical criteria, multimodal computed tomography (CT) imaging. Eighty-four patients were treated with bridging IVT followed by EVT; 62 patients were treated with EVT only. Bridging therapy did not influence endovascular procedure time (P?=?0.71) or number of attempts needed (P?=?0.63). Bleeding from any site was more common in the bridging group (27, 32%) vs. the EVT group (12, 19%) (P?=?0.09). Functional independence modified Rankin Scale after 90 days was slightly higher in the bridging group (44%) vs. the EVT group (42%) (P?=?0.14). Mortality did not differ significantly at 90 days: 17% in the bridging group vs. 21% in EVT alone (P?=?0.57). Both treatment methods showed high recanalization rates: 94% in the bridging group and 89% for EVT alone. Bridging treatment in LVO did not show benefits or elevated risks of complications in comparison to EVT only. The bridging group did not show significantly better neurological outcome or significant impact on procedural parameters vs. EVT alone

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413